Human leukocyte antigen and tumor immunotherapy (Review)
International Journal of Oncology · 2023
DOI: 10.3892/ijo.2023.5516 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Oncology, 2023. Verfasst von Da-Hua Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biological Anthropology Institute, College of Basic Medical Science, Jinzhou Medical University, Jinzhou, Liaoning 121001, P.R. China. Hauptthemen laut MEDLINE: Histocompatibility Antigens Class I, Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Malignant tumors seriously endanger human health and life, and restrict economic development. Human leukocyte antigen (HLA) is the expression product of the human major histocompatibility complex, which, at present, is the most complex known polymorphic system. The polymorphism and expression of HLA molecules have been demonstrated to be associated with the occurrence and development of tumors. HLA molecules can regulate the proliferation of tumor cells and inhibit antitumor immunity. In the present review, the structure and function of HLA molecules, the polymorphism and expression of HLA in tumor tissue, the roles of HLA in tumor cells and tumor immunity, and the potential clinical application of HLA in tumor immunotherapy are summarized. The overall aim of the present review is to provide relevant information for the development of antitumor immunotherapies involving HLA in the clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biological Anthropology Institute, College of Basic Medical Science, Jinzhou Medical University, Jinzhou, Liaoning 121001, P.R. China.
- Department of Nursing, Shijiazhuang Medical College, Shijiazhuang, Hebei 050599, P.R. China.
- Department of Cardiology, Jinzhou Central Hospital, Jinzhou, Liaoning, 121001, P.R. China.
Zitieren
APA
Liu, D. H., Mou, F. F., An, M., & Xia, P. (2023). Human leukocyte antigen and tumor immunotherapy (Review). International Journal of Oncology. https://doi.org/10.3892/ijo.2023.5516
Vancouver
Liu DH, Mou FF, An M, Xia P. Human leukocyte antigen and tumor immunotherapy (Review). International Journal of Oncology. 2023. doi:10.3892/ijo.2023.5516
BibTeX
@article{Liu2023,
author = {Liu, Da-Hua and Mou, Fei-Fei and An, Min and Xia, Pu},
title = {Human leukocyte antigen and tumor immunotherapy (Review)},
journal = {International Journal of Oncology},
year = {2023},
doi = {10.3892/ijo.2023.5516}
}
EUVIMED